Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377546 · ClinicalTrials.gov registry record · Phase 4
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00377546: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00377546 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00377546, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
To compare the penetration of three different NSAIDs.
Interventions
- DRUG Nepafenac
- DRUG Ketorolac LS, Bromfenac
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00377546 record still lists
NCT00377546 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Nepafenac is the first listed.
NCT00377546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00377546 about?
NCT00377546 is a clinical study titled "Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%". To compare the penetration of three different NSAIDs.
What is the current status of trial NCT00377546?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00377546?
The interventions under investigation include: Nepafenac (DRUG), Ketorolac LS, Bromfenac (DRUG).
Who is sponsoring clinical trial NCT00377546?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.